2019
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status
Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D’Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Gibert CL, Bräu N, Brown ST, Roy JA, Taddei TH, Justice AC, Re V. HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status. Journal Of The National Cancer Institute 2019, 112: 747-755. PMID: 31687755, PMCID: PMC7357318, DOI: 10.1093/jnci/djz214.Peer-Reviewed Original ResearchConceptsRisk of HCCHigher HIV RNAHCC risk factorsHIV RNAHIV viremiaHepatocellular carcinomaBaseline cirrhosisCirrhosis statusCohort studyRisk factorsCell percentageVeterans Aging Cohort StudyDevelopment of HCCCurrent HIV RNADetectable HIV viremiaHepatitis C coinfectionAging Cohort StudyDiagnosis of cirrhosisLonger durationDetectable HIVLow CD4C coinfectionCurrent CD4Hazard ratioCancer Registry
2013
Lifetime Drinking Trajectories Among Veterans in Treatment for HIV
Jacob T, Blonigen DM, Upah R, Justice A. Lifetime Drinking Trajectories Among Veterans in Treatment for HIV. Alcohol Clinical And Experimental Research 2013, 37: 1179-1187. PMID: 23448171, PMCID: PMC5596456, DOI: 10.1111/acer.12071.Peer-Reviewed Original ResearchConceptsSevere chronicHIV diagnosisLate onsetVeterans Aging Cohort StudyYoung adultsCourse of drinkingAging Cohort StudyOnset of HIVOnset of treatmentPatterns of drinkingLifetime Drinking HistoryHIV groupCohort studyHIV- participantsTreatment outcomesHIVCurrent studyYounger ageCocaine useDrinking historyDrinking phasesLatent growth mixture modelMedical issuesLonger durationDrinking trajectories